Press Releases
All press releases
New coalition will combat most common barrier to care for people living with schizophrenia
The Schizophrenia & Psychosis Action Alliance (S&PAA) has formed a strategic collaboration with the Henry Amador Center on Anosognosia and the LEAP Institute to create The Anosognosia Coalition, whose goals are to raise insights into and awareness of the destructive condition of anosognosia and create policies to reduce its negative impact on people living with schizophrenia and psychosis disorders.
Landmark Patient-Focused Drug Development Meeting on Schizophrenia Will Spotlight Urgent Need for New, Better Treatments
November 2 event designed to tell drug developers, FDA reviewers what really matters to people living with the brain disease
New Congressional bill will spotlight actual prevalence, cost burden of schizophrenia
The Cost of Mental Illness Act of 2022 authorizes groundbreaking studies to improve system of care for people living with the brain disease
New Board Members Join Our Transformational Movement
Schizophrenia & Psychosis Action Alliance (S&PAA) has launched a bold agenda to lead a system-widemovement for theimprovement of access to medical care, supports and equity for the millions of people living with schizophrenia and psychosis spectrum disorders.
2025 Headlines
All headlines
In the News
We are dedicated to promoting awareness of the latest schizophrenia, psychosis spectrum disorders and related research, resources, and news to help you stay informed.